These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
403 related items for PubMed ID: 19951909
1. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, Massironi S, Della Corte C, Ronchi G, Rumi MG, Biondetti P, Colombo M. Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909 [Abstract] [Full Text] [Related]
2. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma. Manini MA, Sangiovanni A, Fornari F, Piscaglia F, Biolato M, Fanigliulo L, Ravaldi E, Grieco A, Colombo M, Study Participants. J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368 [Abstract] [Full Text] [Related]
3. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, Busuttil RW, Lu DS. Clin Gastroenterol Hepatol; 2011 Feb; 9(2):161-7. PubMed ID: 20920597 [Abstract] [Full Text] [Related]
4. CT and MRI of hepatocellular carcinoma: an update. Ayyappan AP, Jhaveri KS. Expert Rev Anticancer Ther; 2010 Apr; 10(4):507-19. PubMed ID: 20397916 [Abstract] [Full Text] [Related]
6. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions]. Helmberger T, Gregor M, Holzknecht N, Rau H, Scheidler J, Reiser M. Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456 [Abstract] [Full Text] [Related]
7. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI. Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119 [Abstract] [Full Text] [Related]
8. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ. J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216 [Abstract] [Full Text] [Related]
9. Diagnostic accuracy of multi-/single-detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the milan criteria before liver transplantation. Kim SH, Choi BI, Lee JY, Kim SJ, So YH, Eun HW, Lee JM, Han JK. Intervirology; 2008 Jul; 51 Suppl 1():52-60. PubMed ID: 18544949 [Abstract] [Full Text] [Related]
10. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. Khan AS, Hussain HK, Johnson TD, Weadock WJ, Pelletier SJ, Marrero JA. J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263 [Abstract] [Full Text] [Related]
11. Imaging of hepatocellular carcinoma and early diagnosis. Limaye AR, Cabrera R. Minerva Med; 2010 Dec; 101(6):395-404. PubMed ID: 21196899 [Abstract] [Full Text] [Related]
12. Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. Rimola J, Forner A, Tremosini S, Reig M, Vilana R, Bianchi L, Rodríguez-Lope C, Solé M, Ayuso C, Bruix J. J Hepatol; 2012 Jun; 56(6):1317-23. PubMed ID: 22314420 [Abstract] [Full Text] [Related]
13. [Imaging in the screening and diagnosis of hepatocellular carcinoma in cirrhosis liver in Tunisia. A series of 30 cases]. Ben Hassine L, Daghfous MH, Mami A, Chammakhi-Jemli C, Zouaoui W, Saddoud W, Miaoui A, Kharrat J, Ghorbal A, Sehili-Briki S. Tunis Med; 2007 May; 85(5):421-6. PubMed ID: 17657932 [Abstract] [Full Text] [Related]
15. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Brú C, Bruix J. Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697 [Abstract] [Full Text] [Related]
17. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy. Tremolda F, Benevegnù L, Drago C, Casarin C, Cechetto A, Realdi G, Ruol A. Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242 [Abstract] [Full Text] [Related]
18. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Hatanaka K, Kudo M, Minami Y, Maekawa K. Oncology; 2008 Dec; 75 Suppl 1():42-7. PubMed ID: 19092271 [Abstract] [Full Text] [Related]
19. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW. Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015 [Abstract] [Full Text] [Related]
20. Contrast-enhanced ultrasound vs multidetector-computed tomography for detecting liver metastases in colorectal cancer: a prospective, blinded, patient-by-patient analysis. Rafaelsen SR, Jakobsen A. Colorectal Dis; 2011 Apr; 13(4):420-5. PubMed ID: 20412096 [Abstract] [Full Text] [Related] Page: [Next] [New Search]